Cancer diagnosis

Pathological diagnosis - Biopsy

A portion of human tissue or a tissue sample removed through surgery is sent to the pathology department for processing. After processing through techniques such as sectioning and staining, the morphology, structure, tissue arrangement, and changes in chemical composition of cells are observed under a microscope to diagnose its nature. If it is a malignant tumor, its degree of malignancy and stage are further analyzed.

Related Articles

EGFR突變型肺癌治療新選擇!一線 Amivantamab 和 Lazertinib 聯合方案增加生存期!

A new choice for the treatment of EGFR mutant lung cancer! The combined regimen of first-line Amivantamab and Lazertinib increases the survival period!

On August 19, 2024, the U.S. Food and Drug Administration (FDA) approved the combination therapy of lazertinib (Lazcluze) and amivantamab-vmjw (Rybrevant) for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC), and the FDA-approved test with EGFR exon 19 deletion or deletion. Mutation in the exon 21 L858R gene.

Doctor Updates

【240711 Team Medicine Sharing Seminar】 New Trends in the treatment of lung cancer, breast cancer and prostate cancer

With advancements in medicine, cancer treatment has entered an era of precision and personalized care. Taking lung cancer, Hong Kong's leading cancer killer, as an example, next-generation sequencing technology can detect over 300 cancer genes at once, helping doctors screen and find the most appropriate treatment plan or clinical trial program. This not only avoids delaying treatment but also makes better use of limited resources to maximize benefits for patients.

【Medipartner * Medical Seminar】 New Trends in Lung Cancer Treatment and Nutritional Support

With advancements in medicine, cancer treatment has entered an era of precision and personalized care. Taking lung cancer, Hong Kong's leading cancer killer, as an example, next-generation sequencing technology can detect over 300 cancer genes at once, helping doctors screen and find the most appropriate treatment plan or clinical trial program. This not only avoids delaying treatment but also makes better use of limited resources to maximize benefits for patients.